xspa - XSPA STOCK NEWS

XWELL, Inc. (formerly XpresSpa Group, Inc.) announced its corporate rebranding aimed at establishing itself as a leader in health and wellness. Effective October 25, 2022, the ticker symbol changes from XSPA to XWEL. The rebrand underscores the company's transition towards comprehensive wellness solutions for travelers, aligning with its four transformational imperatives for growth. Recent developments include the reopening of XpresSpa at JFK, new locations in Istanbul and Salt Lake City, and a partnership with Ginkgo Bioworks for COVID-19 genomic surveillance initiatives.

XpresSpa Group, Inc. (XSPA) has launched the Women’s Health Initiative, introducing a new range of curated products for women that are clean, sustainable, and primarily sourced from women-owned companies. The initiative aims to promote health and wellness for women, offering products in categories such as personal hygiene and reproductive health. Notable products include Plan B One-Step and August organic cotton products. Additionally, the company will donate a portion of sales in October to Susan G. Komen for breast cancer research, highlighting its commitment to women's health.

XpresSpa Group (XSPA) has been awarded a CDC biosurveillance contract valued at up to $61 million through its partnership with Ginkgo Bioworks. The company reported $13.6 million in revenue for Q2 2022, an increase from $9.1 million in Q2 2021. However, losses from operations grew to $7.8 million in Q2 2022, compared to $4.2 million in the prior year. XpresCheck continues to conduct COVID-19 testing, with 15 locations active in 12 airports and a focus on biosurveillance. The company also plans to expand its retail presence with new spa openings.

XpresSpa Group, Inc. (Nasdaq: XSPA) has announced the re-opening of its prominent XpresSpa™ location at John F. Kennedy International Airport (JFK) in Terminal 4. This facility aims to cater to health-conscious travelers by providing wellness services, including neck and back massages and advanced therapeutic solutions, alongside a broader range of retail products. With 26 locations globally, the company is set to expand internationally, opening new facilities in Turkey and across the Gulf Cooperation Council countries in the coming years.

XpresSpa Group, Inc. (Nasdaq: XSPA) will release its Q2 2022 financial results on August 15, 2022, after market close. A webcast and conference call are scheduled for the same day at 4:30 PM ET. Investors are encouraged to access the webcast due to limited capacity for the call. XpresSpa operates several health and wellness brands, including XpresCheck, which provides Covid-19 testing at 15 airport locations. The company emphasizes its role in travel health and wellness, participating in biosurveillance for SARS-CoV-2 variants through partnerships with the CDC.

XpresSpa Group, Inc. (Nasdaq: XSPA) is set to expand internationally by opening new locations at Istanbul Airport in Turkey, starting September 2022. This will mark the first of five planned XpresSpa locations at the airport, strategically positioned to cater to the increasing travel demand between Europe and Asia. CEO Scott Milford emphasized that this expansion will help leverage their wellness services for international travelers. Currently, XpresSpa operates six locations outside the U.S., and further plans include additional operations in Abu Dhabi.

XpresSpa Group, Inc. (Nasdaq: XSPA) announced the appointment of Omar Haynes as Interim Chief Financial Officer following the separation from James A. Berry effective June 13, 2022. Haynes, who has been with the company since 2017, has held various financial roles including Treasurer. Scott Milford, CEO, expressed gratitude to Berry and confidence in Haynes’s capabilities to guide the company during the transition. XpresSpa operates health and wellness brands, including XpresCheck, a Covid-19 testing provider at airports.